Merck (MRK) Gross Profit (2009 - 2026)
Merck (MRK) recorded Gross Profit of $12.21 billion in Q2 2026, down 0.3% from $12.25 billion a year earlier but up 1.0% from the prior quarter.
Powered by 
Analysis
Merck (MRK) Gross Profit (2009 - 2026) Analysis & Trends
On a TTM basis, Merck's Gross Profit came in at $48.57 billion as of Jun 30, 2026, down 0.3% year-over-year; for FY2025, it came in at $48.63 billion, down 0.7% from FY2024.
- Annual Gross Profit has a five-year compound annual growth rate of 11.8% (FY2020 to FY2025).
- Across earlier years, Gross Profit came in at $48.98 billion in FY2024 (+11.3%), $43.99 billion in FY2023 (+5.1%), $41.87 billion in FY2022 (+19.4%) and $35.08 billion in FY2021 (+25.7%).
- Quarterly Gross Profit has ranged from $9.65 billion in Q4 2021 to $13.42 billion in Q3 2025 over the past five years.
- On a year-over-year basis, Gross Profit has declined for three consecutive quarters, with growth averaging 1.7% over the last eight quarters.
- Peak year-over-year performance for Gross Profit in the last five years was growth of 63.0% in Q4 2021, against a decline of 8.0% in Q4 2025 at the low end.
- Per Business Quant, the preceding three quarters came in at $12.09 billion (Q1 2026), $10.85 billion (Q4 2025) and $13.42 billion (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,122.91 Bn | 1,091.50 Bn | 19.71 Bn |
| 2 | Johnson & Johnson | 615.09 Bn | 533.62 Bn | 17.26 Bn |
| 3 | AbbVie | 504.75 Bn | 477.86 Bn | 12.70 Bn |
| 4 | Merck | 360.18 Bn | 314.55 Bn | 12.21 Bn |
| 5 | Novartis Ag | 292.05 Bn | 256.04 Bn | 11.24 Bn |
| 6 | Astrazeneca | 256.09 Bn | 229.78 Bn | 12.86 Bn |
| 7 | Amgen | 233.63 Bn | 189.02 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 194.49 Bn | 168.69 Bn | 6.22 Bn |
| 9 | Pfizer | 168.35 Bn | 114.99 Bn | 10.94 Bn |
| 10 | Vertex Pharmaceuticals | 126.70 Bn | 98.70 Bn | 2.84 Bn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 12.21 Bn |
| Mar 31, 2026 | 12.09 Bn |
| Dec 31, 2025 | 10.85 Bn |
| Sep 30, 2025 | 13.42 Bn |
| Jun 30, 2025 | 12.25 Bn |
| Mar 31, 2025 | 12.11 Bn |
| Dec 31, 2024 | 11.80 Bn |
| Sep 30, 2024 | 12.58 Bn |
| Jun 30, 2024 | 12.37 Bn |
| Mar 31, 2024 | 12.24 Bn |
| Dec 31, 2023 | 10.72 Bn |
| Sep 30, 2023 | 11.70 Bn |
| Jun 30, 2023 | 11.01 Bn |
| Mar 31, 2023 | 10.56 Bn |
| Dec 31, 2022 | 9.95 Bn |
| Sep 30, 2022 | 11.03 Bn |
| Jun 30, 2022 | 10.38 Bn |
| Mar 31, 2022 | 10.52 Bn |
| Dec 31, 2021 | 9.65 Bn |
| Sep 30, 2021 | 9.70 Bn |
API Access
Merck Gross Profit API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=gross-profit&ticker=MRK&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "gross-profit", "ticker": "MRK", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=gross-profit&ticker=MRK&period=max&api_key=YOUR_API_KEY");
const data = await res.json();